Tau-PI3Kalpha Complex in Regulation of PI3K/Akt-dependent Neuronal Function and Survival
Tau-PI3Kalpha 复合物调节 PI3K/Akt 依赖性神经元功能和存活
基本信息
- 批准号:10710161
- 负责人:
- 金额:$ 19.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
Tau pathologies including Alzheimer’s disease are the most prevalent and complex neurodegenerative diseases
of aging that will likely reach 115 million globally by 2050(6) yet, there are no therapeutic drugs to treat this
disease, except a controversial recently approved drug(7). Though the formation of intracellular neurofibrillary
tangles (NFTs) from the hyperphosphorylated tau protein in the cortical and hippocampal regions is a key
pathological hallmark of tau pathologies, the precise mechanisms of how hyperphosphorylated tau impact
survival signaling in neurons is lacking. Recently we have shown that the PI3K/Akt survival signaling
pathway is controlled by the non-neuronal type microtubule-associated protein 4 (MAP4) that directly interacts
with PI3K via its microtubule-binding domain (MTBD)(9). The PI3K interaction with MAP4 controls the PI3K
association with activated receptor kinases that are required for PI3K activation, PI3,4,5P3 generation, and
Akt activation(9). The MTBD of MAP4 that binds PI3K shows strikingly high homology with the microtubule-
binding domain of the neuronal microtubule-associated proteins tau and MAP2, stimulating the hypothesis that
tau and MAP2 substitute for MAP4 control of PI3K/Akt survival signaling in neurons. Our preliminary data shows
the association between tau and PI3K in primary neurons, induced pluripotent stem cells-derived neurons, and
a neuronal cell line. The siRNA-mediated knockdown of tau blocked insulin stimulated Akt activation.
We hypothesize that tau scaffold the PI3K along microtubules in axons and dendrites to control growth factor
stimulated PI3K/Akt survival signaling of neurons. Increased tau hyperphosphorylation and its aggregation
during Alzheimer’s disease progression impairs the spatial organization of PI3K along microtubules resulting
in loss of growth factor stimulated PI3K/Akt signaling that is critical for neuronal cell survival and function.
The focus of proposed study is to establish and understand mechanistically tau’s role in the PI3K/Akt signaling
and define the PI3K interaction sites in tau. The interaction between PI3K and tau will be used to define the
interaction sites for PI3K in the MTBD of tau and investigate if these sites coincide with pathogenic mutants
and hyperphosphorylation sites in the MTBD of tau. We will define the effect of tau loss on spatial distribution,
co-localization and interaction of PI3K with activated receptors in axons and dendrites, and effect on growth
factor stimulated PI3,4,5P3 generation and Akt activation. This will be further substantiated by a systemic
investigation of the impact of expressing mutant tau that is deficient on PI3K binding and the disruption of
PI3K-tau interaction by cell permeable peptides on spatial PI3K/Akt signaling and survival of neurons.
项目摘要
包括阿尔茨海默氏病在内的TAU病理是最普遍,最复杂的神经退行性疾病
到2050年(6)的衰老可能会达到全球1.15亿次,但是没有治疗药物可以治疗这种药物
疾病,除了有争议的最近批准的药物(7)。虽然细胞内神经原纤维的形成
从皮质和海马区域中的高磷酸化tau蛋白的缠结(NFT)是关键
tau病理学的病理标志,这是高磷酸化tau撞击的精确机制
缺乏神经元中的生存信号传导。最近,我们证明了PI3K/AKT存活信号传导
途径由非神经型微管相关蛋白4(MAP4)控制,该蛋白质直接相互作用
使用PI3K通过其微管结合域(MTBD)(9)。与MAP4的PI3K相互作用控制PI3K
与PI3K激活,PI3,4,53生成和激活的接收器激酶相关
Akt激活(9)。结合PI3K的MAP4的MTBD与微管表现出极高的同源性
神经元微管相关蛋白Tau和Map2的结合结构域,刺激了以下假设
TAU和MAP2代替神经元中PI3K/AKT存活信号的MAP4控制。我们的初步数据显示
tau和pi3k在原发性神经元中,诱导多能干细胞衍生的神经元的关联,以及
神经元细胞系。 siRNA介导的tau敲低阻断胰岛素刺激了Akt激活。
我们假设tau沿轴突和树突的微管沿微管脚手架以控制生长因子
刺激神经元的PI3K/AKT存活信号传导。 tau高磷酸化及其聚集
在阿尔茨海默氏病的过程中,沿微管的PI3K的空间组织损害了导致的PI3K
在生长因子损失中,刺激了对神经元细胞存活和功能至关重要的PI3K/AKT信号。
拟议的研究的重点是从机械上建立和理解tau在PI3K/AKT信号中的作用
并定义tau中的PI3K相互作用位点。 PI3K和Tau之间的相互作用将用于定义
pi3k在tau的MTBD中的相互作用位点,并研究这些位点是否与致病突变体一致
tau的MTBD中的高磷酸化位点。我们将定义tau损失对空间分布的影响,
PI3K与轴突和树突中激活的接收器的共定位和相互作用,对生长的影响
因子刺激PI3,4,53的生成和Akt激活。这将通过系统性进一步证实
对表达突变体Tau的影响的研究,该突变体对PI3KA结合和破坏的影响
PI3K-TAU通过可渗透性的细胞相互作用在空间PI3K/AKT信号传导和神经元的存活率上。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Richard A. Anderson其他文献
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.
在临床试验中测量卵巢毒性:美国临床肿瘤学会研究声明。
- DOI:
- 发表时间:20232023
- 期刊:
- 影响因子:0
- 作者:W. Cui;R. Rocconi;Ramya Thota;Richard A. Anderson;S. Bruinooge;Ioanna A Comstock;N. Denduluri;Audrey Gassman;Julie R Gralow;Karla J. Hutt;L. Amiri;M. Lambertini;John K Leighton;Karen H Lu;S. Mostoufi;Teri Pollastro;Shan Pradhan;H. Saber;Caroline Schenkel;D. Spratt;S. Wedam;K. PhillipsW. Cui;R. Rocconi;Ramya Thota;Richard A. Anderson;S. Bruinooge;Ioanna A Comstock;N. Denduluri;Audrey Gassman;Julie R Gralow;Karla J. Hutt;L. Amiri;M. Lambertini;John K Leighton;Karen H Lu;S. Mostoufi;Teri Pollastro;Shan Pradhan;H. Saber;Caroline Schenkel;D. Spratt;S. Wedam;K. Phillips
- 通讯作者:K. PhillipsK. Phillips
Interactions between protein 4.1 and band 3. An alternative binding site for an element of the membrane skeleton.
蛋白质 4.1 和带 3 之间的相互作用。膜骨架元件的替代结合位点。
- DOI:
- 发表时间:19851985
- 期刊:
- 影响因子:4.8
- 作者:Gary R. PasternackS;Richard A. Anderson;Thomas L. Leto;Vincent T. MarchesiGary R. PasternackS;Richard A. Anderson;Thomas L. Leto;Vincent T. Marchesi
- 通讯作者:Vincent T. MarchesiVincent T. Marchesi
Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men.
性腺功能减退男性中合成雄激素 7 α-甲基-19-去甲睾酮的组织选择性的证据。
- DOI:
- 发表时间:20032003
- 期刊:
- 影响因子:5.8
- 作者:Richard A. Anderson;A. Michael Wallace;N. Sattar;Narendar Kumar;K. SundaramRichard A. Anderson;A. Michael Wallace;N. Sattar;Narendar Kumar;K. Sundaram
- 通讯作者:K. SundaramK. Sundaram
FROM THIENOPYRIDINES TO NITROSOTHIOLS: A NOVEL POTENTIAL MECHANISM OF THIENOPYRIDINES BIOACTIVITY
- DOI:10.1016/s0735-1097(11)61918-910.1016/s0735-1097(11)61918-9
- 发表时间:2011-04-052011-04-05
- 期刊:
- 影响因子:
- 作者:Richard A. Anderson;Shantu Bundhoo;Ewelina Sagan;Jessica Dada;Rebecca Harris;Phillip JamesRichard A. Anderson;Shantu Bundhoo;Ewelina Sagan;Jessica Dada;Rebecca Harris;Phillip James
- 通讯作者:Phillip JamesPhillip James
Effects of chromium and resistive training on muscle strength and body composition.
铬和阻力训练对肌肉力量和身体成分的影响。
- DOI:10.1097/00005768-199601000-0002510.1097/00005768-199601000-00025
- 发表时间:19961996
- 期刊:
- 影响因子:4.1
- 作者:Melissa A. Hallmark;Thomas H. Reynolds;Christopher A. DeSouza;Charles O. Dotson;Richard A. Anderson;Marc A. RogersMelissa A. Hallmark;Thomas H. Reynolds;Christopher A. DeSouza;Charles O. Dotson;Richard A. Anderson;Marc A. Rogers
- 通讯作者:Marc A. RogersMarc A. Rogers
共 38 条
- 1
- 2
- 3
- 4
- 5
- 6
- 8
Richard A. Anderso...的其他基金
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
- 批准号:1038608610386086
- 财政年份:2020
- 资助金额:$ 19.27万$ 19.27万
- 项目类别:
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
- 批准号:1032300710323007
- 财政年份:2020
- 资助金额:$ 19.27万$ 19.27万
- 项目类别:
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
- 批准号:1007786910077869
- 财政年份:2020
- 资助金额:$ 19.27万$ 19.27万
- 项目类别:
Administrative Supplement: Phosphoinositide Signaling in the Cytosol and Nucleus
行政补充:细胞质和细胞核中的磷酸肌醇信号传导
- 批准号:1079913010799130
- 财政年份:2020
- 资助金额:$ 19.27万$ 19.27万
- 项目类别:
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
- 批准号:1056170110561701
- 财政年份:2020
- 资助金额:$ 19.27万$ 19.27万
- 项目类别:
Nuclear Phosphoinositide Control of 3'-end mRNA Processing and Gene Expression
核磷酸肌醇控制 3 端 mRNA 加工和基因表达
- 批准号:90271539027153
- 财政年份:2015
- 资助金额:$ 19.27万$ 19.27万
- 项目类别:
Nuclear Phosphoinositide Control of 3'-end mRNA Processing and Gene Expression
核磷酸肌醇控制 3 端 mRNA 加工和基因表达
- 批准号:91991049199104
- 财政年份:2015
- 资助金额:$ 19.27万$ 19.27万
- 项目类别:
Phosphoinositide Signaling To and Within the Nucleus
进入细胞核和细胞核内的磷酸肌醇信号传导
- 批准号:80592978059297
- 财政年份:2010
- 资助金额:$ 19.27万$ 19.27万
- 项目类别:
Graduate Training in Molecular and Cellular Pharmacology
分子和细胞药理学研究生培训
- 批准号:78921147892114
- 财政年份:2009
- 资助金额:$ 19.27万$ 19.27万
- 项目类别:
Phosphatidylinositol (PI) Signaling Role in Ephitelial / Mesenchymal Transition
磷脂酰肌醇 (PI) 在上皮/间质转化中的信号作用
- 批准号:73930897393089
- 财政年份:2004
- 资助金额:$ 19.27万$ 19.27万
- 项目类别:
相似国自然基金
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:1066033210660332
- 财政年份:2023
- 资助金额:$ 19.27万$ 19.27万
- 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:1067834110678341
- 财政年份:2023
- 资助金额:$ 19.27万$ 19.27万
- 项目类别:
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
视网膜健康和疾病中光感受器有氧糖酵解的调节因子
- 批准号:1071782510717825
- 财政年份:2023
- 资助金额:$ 19.27万$ 19.27万
- 项目类别:
Dopaminergic mechanisms of resilience to Alzheimer's disease neuropathology
阿尔茨海默病神经病理学恢复的多巴胺能机制
- 批准号:1080919910809199
- 财政年份:2023
- 资助金额:$ 19.27万$ 19.27万
- 项目类别:
Towards the discovery of Nurr1-RXR modulators
致力于发现 Nurr1-RXR 调制器
- 批准号:1075040910750409
- 财政年份:2023
- 资助金额:$ 19.27万$ 19.27万
- 项目类别: